Consensus Cipla Limited LUXEMBOURG S.E.

Stocks

CIPLA

US1729772095

Pharmaceuticals

End-of-day quote LUXEMBOURG S.E. 2026-10-16			5-day change	1st Jan Change
14.00 ^USD	0.00%		+3.70%	-16.67%

10-06	Cipla Health Announces Appointment of Gaurav Kaul as Managing Director, Effective October 2026	CI
09-22	Cipla Limited and Cipla Usa Inc. Announces Management Changes, Effective October 1, 2026	CI

26215893d0400dc3fde998b97211.GxLbQGJ5fTAzYAZAVEO-O0iWAjmxWyAND7LoIsFCOa0.eEazBFFJOmVsMXAYJnHvDBjfVm2FOXh4feS3b4UQap50XZxzCS0pZ1EXUw~53e9f17c9cd4447d842005a32ffac7ee

Analysts' recommendations: Cipla Limited

07-24	Jefferies Adjusts Cipla's Price Target to INR1,170 From INR1,120, Keeps at Underperform	MT
06-24	Avendus Spark Upgrades Cipla to Buy from Add; Price Target is INR1,710	MT
05-14	Elara Securities Downgrades Cipla to Reduce from Accumulate; Price Target is INR1,349	MT
05-14	Elara Securities Downgrades Cipla to Sell from Neutral; Price Target is INR1,180	MT
05-14	JM Financial Upgrades Cipla to Buy from Add; Price Target is INR1,546	MT
05-14	Emkay Global Upgrades Cipla to Add from Reduce; Price Target is INR1,450	MT
05-14	Avendus Spark Upgrades Cipla to Add from Reduce; Price Target is INR1,455	MT
05-14	Nirmal Bang Downgrades Cipla to Hold from Buy; Price Target is INR1,404	MT
05-08	Jefferies Adjusts Cipla's Price Target to INR1,120 From INR1,170, Keeps at Underperform	MT
04-24	ICICI Securities Upgrades Cipla to Buy from Add; Price Target is INR1,550	MT
01-27	Nomura Adjusts Cipla's Price Target to INR1,510 From INR1,770, Keeps at Buy	MT
01-26	Jefferies Downgrades Cipla to Underperform From Hold, Adjusts Price Target to INR1,170 From INR1,630	MT
11-03	Nomura Adjusts Cipla's Price Target to INR1,770 From INR1,810, Keeps at Buy	MT
25-10-31	Choice Equity Downgrades Cipla to Add from Buy; Price Target is INR1,700	MT
25-10-31	Choice Equity Downgrades Cipla to Reduce from Add, Price Target is INR1,580	MT
25-10-31	Phillip Securities Upgrades Cipla to Neutral from Sell; Price Target is INR1,420	MT
25-10-31	Prabhudas Lilladher Downgrades Cipla to Accumulate from Buy, Price Target is INR1,675	MT
25-10-31	JM Financial Downgrades Cipla to Reduce from Hold; Price Target is INR1,600	MT
25-07-29	Nomura Adjusts Cipla's Price Target to INR1,810 From INR1,780, Keeps at Buy	MT
25-05-14	Jefferies Adjusts Cipla's Price Target to INR1,610 From INR1,580, Keeps at Hold	MT
25-01-31	Nomura Adjusts Cipla's Price Target to INR1,780 From INR1,800, Keeps at Buy	MT
25-01-29	Jefferies Adjusts Cipla's Price Target to INR1,580 From INR1,560, Keeps at Hold	MT
24-11-05	Nomura Upgrades Cipla to Buy From Neutral, Adjusts Price Target to INR1,800 From INR1,568	MT
24-10-30	Jefferies Adjusts Cipla's Price Target to INR1,480 From INR1,450, Keeps at Hold	MT
24-07-29	Jefferies Adjusts Cipla's Price Target to INR1,450 From INR1,400, Keeps at Hold	MT

More recommendations

Generic Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ELI LILLY AND COMPANY					+5.65%
	JOHNSON & JOHNSON					+9.33%
	ABBVIE INC.					-0.99%
	ROCHE HOLDING AG					-0.52%
	MERCK & CO., INC.					+8.56%
	NOVARTIS AG					-0.8%
	ASTRAZENECA PLC					+26.78%
	AMGEN INC.					-8.67%
	GILEAD SCIENCES, INC.					+2.34%
	Average					+4.63%
	Weighted average by Cap.					+4.96%